Locations:

Gynecologic Oncology

December 15, 2021/Ob/Gyn & Women’s Health/Gynecologic Oncology

PARP Inhibitors Decrease Response to Subsequent Platinum-Based Chemotherapy in Recurrent Ovarian Cancer

Analysis suggests association between prior PARP inhibition and subsequent decreased progression-free survival in platinum-sensitive ovarian cancer

November 11, 2021/Ob/Gyn & Women’s Health/Gynecologic Oncology

Vaginal Insert Offers Relief from Fecal Incontinence

Device provides alternative to conservative management and surgical procedures

April 23, 2021/Cancer

Hyperthermic Intraperitoneal Chemotherapy with Cisplatin and Paclitaxel Improves Progression-Free Survival Compared with Cisplatin Alone

Combination improves outcomes without increasing postoperative morbidity

March 4, 2021/Cancer

Primary Cytoreductive Surgery Improves Survival Significantly Compared with Other Types of Treatment

A new study explores survival outcomes based on treatment modality

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

March 3, 2021/Ob/Gyn & Women’s Health/Gynecologic Oncology

Antibiotics Prior to Immunotherapy Associated With Decreased Survival in Recurrent Gynecologic Cancers

Study finds 10-month survival difference

February 24, 2021/Cancer

Oncologic and Reproductive Outcomes Following Fertility-Sparing Surgery for Early Cervical Cancer

Analysis suggests disease outcomes comparable to traditional procedures

December 21, 2020/Ob/Gyn & Women’s Health/Gynecologic Oncology

Research Finds Antibiotic Use During Chemotherapy Is Associated With Decreased Overall Survival in Women With Epithelial Ovarian Cancer

Caution warranted when prescribing antibiotics to these patients

December 11, 2020/Ob/Gyn & Women’s Health/Gynecologic Oncology

The Profound Impact of Philanthropy in Women’s Health Research

Announcing the Lilli and Seth Harris Endowed Chair for Ovarian Cancer

BackPage 2 of 2Next